| 2024-03 |
Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort Study |
Targeted Oncology
|
| 2023-11 |
Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy |
JAMA Surgery
|
| 2023-10 |
Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer |
British Journal of Cancer
|
| 2023-09 |
East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective |
Journal of Gynecologic Oncology
|
| 2023-05 |
Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment |
Cancers
|
| 2023-05 |
TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway |
Nature communications
|
| 2023-05 |
High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer |
Oncology reports
|
| 2023-03 |
Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer |
Frontiers in Oncology
|
| 2023-02 |
High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer
|
International Journal of Molecular Sciences
|
| 2023-01 |
Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer |
Annals of Laboratory Medicine
|
| 2022-12 |
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes |
CLINICAL CANCER RESEARCH
|
| 2022-11 |
TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis |
Cancer Genomics and Proteomics
|
| 2022-11 |
RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer |
JOURNAL OF GENE MEDICINE
|
| 2022-10 |
Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047) |
INTERNATIONAL JOURNAL OF CANCER
|
| 2022-10 |
NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells |
Journal of Cellular and Molecular Medicine
|
| 2022-07 |
Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients |
AMERICAN JOURNAL OF CANCER RESEARCH
|
| 2022-06 |
BRAK and APRIL as novel biomarkers for ovarian tumors |
BIOMARKERS IN MEDICINE
|
| 2022-05 |
NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59 |
SCIENTIFIC REPORTS
|
| 2022-03 |
Identification of a novel gene signature in second-trimester amniotic fluid for the prediction of preterm birth |
SCIENTIFIC REPORTS
|
| 2022-02 |
Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models |
Cancers
|
| 2022-01 |
Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer |
Current Issues in Molecular Biology
|
| 2021-11 |
CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer |
CANCER GENOMICS & PROTEOMICS
|
| 2021-07 |
Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial |
EXPERIMENTAL AND THERAPEUTIC MEDICINE
|
| 2021-05 |
Clinical significance of tumor infiltrating lymphocytes in association with hormone receptor expression patterns in epithelial ovarian cancer |
International Journal of Molecular Sciences
|
| 2021-05 |
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial |
LANCET ONCOLOGY
|
| 2021-05 |
The Combination of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) is an Effective Prognostic Biomarker in Cervical Cancer |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
|
| 2021-04 |
Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma |
MOLECULAR ONCOLOGY
|
| 2021-04 |
LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells |
AUTOPHAGY
|
| 2021-01 |
MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors |
PLOS PATHOGENS
|
| 2020-11 |
Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer |
Cancers
|
| 2020-05 |
TOM40 inhibits ovarian cancer cell growth by modulating mitochondrial function including intracellular ATP and ROS levels |
Cancers
|
| 2020-05 |
Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer |
CANCER GENOMICS & PROTEOMICS
|
| 2020-01 |
HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors |
NATURE COMMUNICATIONS
|
| 2019-12 |
Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer |
BMC CANCER
|
| 2019-11 |
Clear Cell Carcinoma Arising from Endometriosis at the Cesarean Scar Site: A Case Report |
Archives of Clinical and Medical Case Reports
|
| 2019-11 |
Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer |
CANCER GENOMICS & PROTEOMICS
|
| 2019-10 |
ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer |
Cancers
|
| 2019-06 |
Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth |
INTERNATIONAL JOURNAL OF HYPERTHERMIA
|
| 2019-01 |
Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
CANCER RESEARCH AND TREATMENT
|
| 2018-12 |
Current Status of Human Papillomavirus Infection and Introduction of Vaccination to the National Immunization Program in Korea: an Overview |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
| 2018-11 |
Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer |
BIOMED RESEARCH INTERNATIONAL
|
| 2018-10 |
Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression |
PLOS ONE
|
| 2018-08 |
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer |
BRITISH JOURNAL OF CANCER
|
| 2018-08 |
Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance |
JOURNAL OF CLINICAL INVESTIGATION
|
| 2018-08 |
DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer |
Cancers
|
| 2018-08 |
Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer. |
SCIENTIFIC REPORTS
|
| 2018-07 |
Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models. |
CANCER RESEARCH AND TREATMENT
|
| 2018-07 |
Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2. |
CANCER RESEARCH AND TREATMENT
|
| 2018-05 |
Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas |
Obstetrics & Gynecology Science
|
| 2018-05 |
Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer. |
GYNECOLOGIC ONCOLOGY
|
| 2018-05 |
Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis |
CANCER RESEARCH
|
| 2018-01 |
An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021) |
CANCER RESEARCH AND TREATMENT
|
| 2017-12 |
The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis |
BIOMED RESEARCH INTERNATIONAL
|
| 2017-09 |
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial. |
LANCET ONCOLOGY
|
| 2017-09 |
API5 induces cisplatin resistance through FGFR signaling in human cancer cells |
EXPERIMENTAL AND MOLECULAR MEDICINE
|
| 2017-09 |
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells. |
CANCER RESEARCH
|
| 2017-09 |
Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer |
ANTICANCER RESEARCH
|
| 2017-05 |
Association of isolated single umbilical artery with perinatal outcomes: Systemic review and meta-analysis. |
Obstetrics & Gynecology Science
|
| 2017-01 |
API5 confers cancer stem cell-like properties through the FGF2-NANOG axis |
Oncogenesis
|
| 2017-01 |
Preoperative Assessment of Lymph Node Metastasis in Endometrial Cancer: A Korean Gynecologic Oncology Group Study |
CANCER
|
| 2016-11 |
Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer |
ONCOTARGET
|
| 2016-10 |
Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women. |
GYNECOLOGIC ONCOLOGY
|
| 2016-09 |
Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue |
ONCOTARGET
|
| 2016-07 |
Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer |
ONCOTARGET
|
| 2016-05 |
Relationship Between Gonadotropin-Releasing Hormone/Gonadotropin-Releasing Hormone Receptor Signaling and Progesterone Receptors in Human Trophoblasts |
JOURNAL OF REPRODUCTIVE MEDICINE
|
| 2016-05 |
Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients. |
JOURNAL OF TRANSLATIONAL MEDICINE
|
| 2016-05 |
Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer |
YONSEI MEDICAL JOURNAL
|
| 2016-02 |
Over-expression of BMI1 is associated with favorable prognosis in cervical cancer |
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
|
| 2016-01 |
Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea. |
BMC CANCER
|
| 2016-01 |
Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology |
MEDICINE
|
| 2015-12 |
Clinical significance of OCT4 and SOX2 protein expression in cervical cancer |
BMC CANCER
|
| 2015-11 |
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. |
ONCOTARGET
|
| 2015-10 |
Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer |
PATHOBIOLOGY
|
| 2015-07 |
PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. |
NATURE COMMUNICATIONS
|
| 2015-06 |
The Korean guideline for cervical cancer screening |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
| 2015-01 |
Asian Society of Gynecologic Oncology International Workshop 2014 |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
| 2014-12 |
MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer. |
BMC CANCER
|
| 2014-11 |
ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer |
YONSEI MEDICAL JOURNAL
|
| 2014-10 |
Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer |
JOURNAL OF CLINICAL ONCOLOGY
|
| 2014-09 |
A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
| 2014-07 |
Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer |
BMC CANCER
|
| 2014-06 |
The role of S100A14 in epithelial ovarian tumors |
ONCOTARGET
|
| 2014-06 |
Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer |
PLOS ONE
|
| 2014-04 |
Expression of Stress-Induced Phosphoprotein1 (STIP1) is Associated with Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer |
GENES CHROMOSOMES & CANCER
|
| 2013-11 |
Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer |
BIOMARKERS
|
| 2013-11 |
Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer. |
CANCER INVESTIGATION
|
| 2013-08 |
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry. |
JOURNAL OF TRANSLATIONAL MEDICINE
|
| 2013-07 |
Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer. |
HUMAN PATHOLOGY
|